Giulia Magini

1.7k total citations
28 papers, 259 citations indexed

About

Giulia Magini is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Giulia Magini has authored 28 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hepatology, 12 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Giulia Magini's work include Liver Disease Diagnosis and Treatment (12 papers), Liver Disease and Transplantation (10 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Giulia Magini is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Liver Disease and Transplantation (10 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Giulia Magini collaborates with scholars based in Italy, Switzerland and Argentina. Giulia Magini's co-authors include Franco Trevisani, Nicolas Goossens, Laurent Spahr, Konstantinos Gkouvatsos, E. Fournier, Nathalie Vernaz, Isabelle Neyroud‐Caspar, Emiliano Giostra, Jean‐Louis Frossard and Francesco Negro and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hepatology and The American Journal of Gastroenterology.

In The Last Decade

Giulia Magini

24 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giulia Magini Italy 8 158 143 49 46 34 28 259
Naotaka Shimozato Japan 13 158 1.0× 177 1.2× 31 0.6× 58 1.3× 12 0.4× 34 342
Masahiro Hatooka Japan 9 237 1.5× 129 0.9× 26 0.5× 83 1.8× 24 0.7× 15 289
Tsukasa Kawaguchi Japan 8 159 1.0× 201 1.4× 30 0.6× 83 1.8× 9 0.3× 9 326
Evangelia Fatourou United Kingdom 13 223 1.4× 149 1.0× 45 0.9× 93 2.0× 13 0.4× 20 351
Dieter Lederer Austria 3 57 0.4× 183 1.3× 38 0.8× 23 0.5× 25 0.7× 5 272
Courtney B. Sherman United States 5 142 0.9× 142 1.0× 36 0.7× 94 2.0× 12 0.4× 14 318
Wei‐Fan Hsu Taiwan 12 220 1.4× 193 1.3× 39 0.8× 90 2.0× 11 0.3× 45 365
In Young Bae South Korea 6 162 1.0× 224 1.6× 40 0.8× 87 1.9× 10 0.3× 8 326
Yuki Ohmoto Japan 6 158 1.0× 261 1.8× 24 0.5× 81 1.8× 55 1.6× 13 358
Shinji Iwane Japan 11 237 1.5× 241 1.7× 31 0.6× 76 1.7× 9 0.3× 34 425

Countries citing papers authored by Giulia Magini

Since Specialization
Citations

This map shows the geographic impact of Giulia Magini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Magini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Magini more than expected).

Fields of papers citing papers by Giulia Magini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Magini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Magini. The network helps show where Giulia Magini may publish in the future.

Co-authorship network of co-authors of Giulia Magini

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Magini. A scholar is included among the top collaborators of Giulia Magini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Magini. Giulia Magini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ielasi, Luca, Bernardo Stefanini, Fabio Conti, et al.. (2024). Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy. Current Oncology. 31(1). 547–557. 2 indexed citations
2.
Stefanini, Bernardo, Francesco Tovoli, Franco Trevisani, et al.. (2024). Prediction of cardiovascular risk in patients with hepatocellular carcinoma receiving anti-angiogenic drugs: lessons from sorafenib. Internal and Emergency Medicine. 19(4). 1151–1160. 4 indexed citations
3.
Vionnet, Julien, et al.. (2024). A false positive hair ethylglucuronide dosage in an alcohol abstinent patient after liver transplantation: a case report. Frontiers in Medicine. 11. 1363012–1363012. 2 indexed citations
4.
Ielasi, Luca, Francesco Tovoli, Bernardo Stefanini, et al.. (2023). Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma. Cancers. 15(5). 1523–1523. 4 indexed citations
5.
Goossens, Nicolas, et al.. (2023). Quel patient adresser à un centre de transplantation hépatique ?. Revue Médicale Suisse. 19(839). 1563–1567.
6.
Goossens, Nicolas, et al.. (2023). Actualisation du suivi d’un patient atteint de cirrhose. Revue Médicale Suisse. 19(839). 1558–1562.
7.
Becchetti, Chiara, Melisa Dirchwolf, Giulia Magini, et al.. (2022). Use of statins after liver transplantation is associated with improved survival: results of a nationwide study. Alimentary Pharmacology & Therapeutics. 56(7). 1194–1204. 16 indexed citations
8.
Becchetti, Chiara, Melisa Dirchwolf, Giulia Magini, et al.. (2022). Use of statins after liver transplantation is associated with improved survival: results of a nationwide study. Journal of Hepatology. 77. S780–S780. 3 indexed citations
9.
Magini, Giulia, Belén Ponte, Anne‐Laure Rougemont, et al.. (2021). Management of Acute Wilsonian Hepatitis with Severe Hemolysis: A Successful Combination of Chelation and MARS Dialysis. SHILAP Revista de lepidopterología. 2021. 1–6. 4 indexed citations
10.
Ielasi, Luca, Francesco Tovoli, Raffaella Tortora, et al.. (2021). Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple Confounders. Cancers. 13(24). 6376–6376. 14 indexed citations
11.
Neyroud‐Caspar, Isabelle, Laurent Spahr, Konstantinos Gkouvatsos, et al.. (2021). NAFLD and MAFLD as emerging causes of HCC: A populational study. JHEP Reports. 3(2). 100231–100231. 88 indexed citations
12.
Sansone, Vito, Francesco Tovoli, Andrea Casadei‐Gardini, et al.. (2021). Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib. Clinical and Translational Gastroenterology. 12(1). e00286–e00286. 12 indexed citations
13.
Bizouard, Geoffray, Martina Gambato, Roberto Montalti, et al.. (2014). P915 PREDICTION OF RECURRENCE AFTER LIVER TRANSPLANTATION FOR HCC: VALIDATION OF THE AFP MODEL IN AN ITALIAN COHORT. Journal of Hepatology. 60(1). S380–S380. 2 indexed citations
14.
Magini, Giulia, Mohsen Farsad, M. Frigerio, et al.. (2009). C-11 Acetate Does Not Enhance Usefulness of F-18 FDG PET/CT in Differentiating Between Focal Nodular Hyperplasia and Hepatic Adenoma. Clinical Nuclear Medicine. 34(10). 659–665. 16 indexed citations
15.
Santi, Valentina, Federica Mirici-Cappa, Giulia Magini, et al.. (2008). Telangiectasia as a Presenting Sign of Graves’ Disease. Hormone Research in Paediatrics. 69(3). 189–192. 1 indexed citations
16.
Trevisani, Franco, Giulia Magini, Valentina Santi, et al.. (2007). Impact of Etiology of Cirrhosis on the Survival of Patients Diagnosed With Hepatocellular Carcinoma During Surveillance. CME. The American Journal of Gastroenterology. 102(5). 1022–1031. 47 indexed citations
17.
Zambruni, A., Franco Trevisani, Veit Gülberg, et al.. (2006). Daily profile of circulating C-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects: Relationship with renal function. Scandinavian Journal of Gastroenterology. 42(5). 642–647. 4 indexed citations
18.
Rizzo, Nicola, Marcello Lanari, Antonio Farina, et al.. (2005). Ultrasound Screening for Congenital Pyelectasis in Term Pregnancies. American Journal of Perinatology. 22(5). 265–267. 2 indexed citations
19.
Cappa, Federica Mirici, Mireille Cantarini, Giulia Magini, et al.. (2005). Effects of the combined treatment with thalidomide, megestrol and interleukine-2 in cirrhotic patients with advanced hepatocellular carcinoma☆A pilot study. Digestive and Liver Disease. 37(4). 254–259. 7 indexed citations
20.
Maseri, A, Paola Mancini, Antonio L’Abbate, & Giulia Magini. (1972). Method for regional dynamic study of myocardial blood flow in man.. PubMed. 15(2). 54–7. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naotaka Shimozato Breakdown of academic impact, for papers by Masahiro Hatooka Breakdown of academic impact, for papers by Tsukasa Kawaguchi Breakdown of academic impact, for papers by Evangelia Fatourou Breakdown of academic impact, for papers by Dieter Lederer Breakdown of academic impact, for papers by Courtney B. Sherman Breakdown of academic impact, for papers by Wei‐Fan Hsu Breakdown of academic impact, for papers by In Young Bae Breakdown of academic impact, for papers by Yuki Ohmoto Breakdown of academic impact, for papers by Shinji Iwane
Rankless by CCL
2026